Eli Lilly and Co. has appointed two new Executive Committee members and has expanded other senior leaders’ roles to support the company in its next wave of growth. Carole Ho, M.D., will join Lilly as executive vice president and president, Lilly Neuroscience, and will serve on the Executive Committee. Ho brings more than 20 years of biopharmaceutical experience leading therapeutic development across neurology, rare diseases, immunology, and other areas. Most recently, she served as chie...